Two studies published in Nature found stem-cell derived products can not only be safely transplanted into the brain, but also ...

The advisory committee, which met Tuesday for the first time since Robert F. Kennedy Jr. was sworn in as health secretary, ...

The president’s executive order promising to lower pharmaceutical prices includes support for a fix long sought by the ...

The biotech is developing an experimental drug for the most common of a family of disorders all caused by errors in ...

After a lengthy regulatory back-and-forth, Eisai and Biogen's Alzheimer's drug is on the market in Europe. Elsewhere, Sandoz is alleging Amgen's patent actions were anticompetitive.